These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12657927)

  • 21. [Use of biopsy results to predict capsular perforation and seminal vesicle invasion in prostate cancer].
    Li G; Yuan Y; Zhang J; Yang X; Xia T; Guo Y; Na Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Dec; 35(6):581-5. PubMed ID: 14710248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer.
    Ross JS; Figge H; Bui HX; del Rosario AD; Jennings TA; Rifkin MD; Fisher HA
    Cancer; 1994 Nov; 74(10):2811-8. PubMed ID: 7954242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings.
    Karram S; Trock BJ; Netto GJ; Epstein JI
    Am J Surg Pathol; 2011 Sep; 35(9):1351-5. PubMed ID: 21836493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database.
    Freedland SJ; Aronson WJ; Csathy GS; Kane CJ; Amling CL; Presti JC; Dorey F; Terris MK;
    Urology; 2003 Apr; 61(4):742-7. PubMed ID: 12670558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of perineural invasion and other biopsy characteristics as prognostic markers for localized prostate cancer.
    Epstein JI
    Semin Urol Oncol; 1998 Aug; 16(3):124-8. PubMed ID: 9741416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis.
    Ellis CL; Partin AW; Han M; Epstein JI
    J Urol; 2013 Dec; 190(6):2068-73. PubMed ID: 23727307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate biopsy perineural invasion is not independently associated with positive surgical margins following radical retropubic prostatectomy.
    Ristau BT; Tomaszewski JJ; Chen YF; Bertolet M; Woldemichael E; Nelson JB
    World J Urol; 2015 Sep; 33(9):1269-74. PubMed ID: 25366883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomograms.
    Gancarczyk KJ; Wu H; McLeod DG; Kane C; Kusuda L; Lance R; Herring J; Foley J; Baldwin D; Bishoff JT; Soderdahl D; Moul JW
    Urology; 2003 Mar; 61(3):589-95. PubMed ID: 12639653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).
    Epstein JI; Walsh PC; Brendler CB
    J Urol; 1994 Nov; 152(5 Pt 2):1721-9. PubMed ID: 7523719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ability of sextant biopsies to predict radical prostatectomy stage.
    Wills ML; Sauvageot J; Partin AW; Gurganus R; Epstein JI
    Urology; 1998 May; 51(5):759-64. PubMed ID: 9610589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy.
    DeLancey JO; Wood DP; He C; Montgomery JS; Weizer AZ; Miller DC; Jacobs BL; Montie JE; Hollenbeck BK; Skolarus TA
    Urology; 2013 Feb; 81(2):354-7. PubMed ID: 23374801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Various morphometric measurements of cancer extent on needle prostatic biopsies: which is predictive of pathologic stage and biochemical recurrence following radical prostatectomy?
    Quintal MM; Meirelles LR; Freitas LL; Magna LA; Ferreira U; Billis A
    Int Urol Nephrol; 2011 Sep; 43(3):697-705. PubMed ID: 21340462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative prediction of surgical margin status in patients with prostate cancer treated by radical prostatectomy.
    Cheng L; Slezak J; Bergstralh EJ; Myers RP; Zincke H; Bostwick DG
    J Clin Oncol; 2000 Aug; 18(15):2862-8. PubMed ID: 10920134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biopsy Quantitative Patohistology and Seral Values of Prostate Specific Antigen-Alpha (1) Antichymotrypsine Complex in Prediction of Adverse Pathology Findings after Radical Prostatectomy.
    Tomasković I; Milicić V; Tomić M; Ruzić B; Ulamec M
    Coll Antropol; 2015 Sep; 39(3):691-5. PubMed ID: 26898067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of perineural invasion in prostate needle biopsy on tumor grade and biochemical recurrence rates after radical prostatectomy.
    Celik S; Bozkurt O; Demir O; Gurboga O; Tuna B; Yorukoglu K; Aslan G
    Kaohsiung J Med Sci; 2018 Jul; 34(7):385-390. PubMed ID: 30063011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
    J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance?
    Chen DJ; Falzarano SM; McKenney JK; Przybycin CG; Reynolds JP; Roma A; Jones JS; Stephenson A; Klein E; Magi-Galluzzi C
    BJU Int; 2015 Aug; 116(2):220-9. PubMed ID: 25060664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excision of the neurovascular bundle at radical prostatectomy in cases with perineural invasion on needle biopsy.
    Holmes GF; Walsh PC; Pound CR; Epstein JI
    Urology; 1999 Apr; 53(4):752-6. PubMed ID: 10197851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.
    Epstein JI; Walsh PC; Carmichael M; Brendler CB
    JAMA; 1994 Feb; 271(5):368-74. PubMed ID: 7506797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parameters of perineural invasion in radical prostatectomy specimens lack prognostic significance.
    Merrilees AD; Bethwaite PB; Russell GL; Robinson RG; Delahunt B
    Mod Pathol; 2008 Sep; 21(9):1095-100. PubMed ID: 18500264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.